Sodium butyrate decreases the activation of NF-κB reducing inflammation and oxidative damage in the kidney of rats subjected to contrast-induced nephropathy

Nephrology Dialysis Transplantation

Volumn 27, Issue 8, 2012, Pages 3136-3140

  MacHado, Roberta Albino ^a   Constantino, Larissa De Souza ^a   Tomasi, Cristiane Damiani ^a   Rojas, Hugo Alberto ^a   Vuolo, Francieli Silva ^a   Vitto, Marcelo Fontana ^b   Cesconetto, Patrícia Acordi ^b   De Souza, Cláudio Teodoro ^b   Ritter, Cristiane ^a   Dal Pizzol, Felipe ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

acute kidney injury; contrast induced nephropathy; nephrotoxicity; sodium butyrate

Indexed keywords

BUTYRIC ACID; CREATININE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; IMMUNOBLOTTING; KIDNEY TUBULE DAMAGE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RAT; RENAL PROTECTION; SIGNAL TRANSDUCTION; TREATMENT DURATION;

ACUTE KIDNEY INJURY; ANIMALS; BUTYRATES; CELL ADHESION MOLECULES; CONTRAST MEDIA; CREATININE; INFLAMMATION; INTERLEUKIN-6; KIDNEY; MALE; MICROFILAMENT PROTEINS; NF-KAPPA B; OXIDATION-REDUCTION; PHOSPHOPROTEINS; RATS; RATS, WISTAR;

EID: 84864609051     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr807     Document Type: Article

References (26)

1. Solomon R, Dauerman HL Contrast-induced acute kidney injury. Circulation 2010; 122: 2451-2455.
2. Persson PB, Hansell P, Liss P Pathophysiology of contrast mediuminduced nephropathy. Kidney Int 2005; 68: 14-22.
3. Solomon R Contrast-induced acute kidney injury: is there a risk after intravenous contrast?. Clin J Am Soc Nephrol 2008; 3: 1274-1281.
4. Heyman SN, Rosen S, Rosenberger C Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy. Clin J Am Soc Nephrol 2008; 3: 288-296.
5. Hinnebusch BF, Meng S, Wu JT et al. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2001; 132: 1012-1017.
6. Kien CL, Chang JC, Cooper JR Butyric acid is synthesized by piglets. J Nutr 2000; 130: 234-237.
7. Medina V, Edmonds B, Young GP et al. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. Cancer Res 1997; 57: 3697-3707.
8. Safaya S, Klings ES, Odhiambo A et al. Effect of sodium butyrate on lung vascular TNFSF15 (TL1A) expression: differential expression patterns in pulmonary artery and microvascular endothelial cells. Cytokine 2009; 46: 72-78.
9. Giuliano M, Lauricella M, Calvaruso G et al. The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells. Cancer Res 1999; 59: 5586-5595.
10. Yin L, Laevsky G, Giardina C Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J Biol Chem 2001; 276: 44641-44646.
11. Quivy V, Lint CV Regulation at multiple levels of NF-kB-mediated transactivation by protein acetylation. Biochem Pharmacol 2004; 68: 1221-1229.
12. Profirovic J, Gorovoy M, Niu J et al. A novel mechanism of G protein-dependent phosphorylation of vasodilator-stimulated phosphoprotein. J Biol Chem 2005; 280: 32866-32876.
13. Wang X, Pluznick JL, Settles DC et al. Association of VASP with TRPC4 in PKG-mediated inhibition of the store-operated calcium response in mesangial cells. Am J Physiol Renal Physiol 2007; 293: F1768-F1776.
14. Li Calzi S, Purich DL, Chang KH et al. Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes. Diabetes 2008; 57: 2488-2494.
15. Esterbauer H, Cheeseman KH Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-421.
16. Levine RL, Garland D, Oliver CN et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-478.
17. Bradford MM A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
18. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 15: 680-685.
19. De Souza CT, Gasparetti AL, Pereira-da-Silva M et al. Peroxisome proliferator-activated receptor gamma coactivator-1-dependent uncoupling protein-2 expression in pancreatic islets of rats: a novel pathway for neural control of insulin secretion. Diabetologia 2003; 46: 1522-1531.
20. Toprak O, Cirit M, Tanrisev M et al. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant 2008; 23: 853-859.
21. Kim HJ, Rowe M, Ren M et al. Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. J Pharmacol Exp Ther 2007; 321: 892-901.
22. Zhang IT, Jin S, Wang C et al. Histone deacetylase inhibitors attenuate acute lung injury during cecal ligation and puncture-induced polymicrobial sepsis. World J Surg 2010; 34: 1676-1683.
23. Zhang LT, Yao YM, Lu JQ et al. Sodium butyrate prevents lethality of severe sepsis in rats. Shock 2007; 27: 672-677.
24. Heyman SN, Rosen S, Khamaisi M et al. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Invest Radiol 2010; 45: 188-195.
25. Bajwa A, Kinsey GR, Okusa MD Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets 2009; 10: 1196-1204.
26. Erdogan H, Fadillioglu E, Yagmurca M et al. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 2006; 34: 41-46